FI925778A0 - Farmaceutiskt aktiva bensokinazolinfoereningar - Google Patents

Farmaceutiskt aktiva bensokinazolinfoereningar

Info

Publication number
FI925778A0
FI925778A0 FI925778A FI925778A FI925778A0 FI 925778 A0 FI925778 A0 FI 925778A0 FI 925778 A FI925778 A FI 925778A FI 925778 A FI925778 A FI 925778A FI 925778 A0 FI925778 A0 FI 925778A0
Authority
FI
Finland
Prior art keywords
active
benzoquinazoline
pharmaceutical
active ingredient
ingredient
Prior art date
Application number
FI925778A
Other languages
English (en)
Other versions
FI925778A (fi
Inventor
William Pendergast
Scott Howard Dickerson
Julius Vass Johnson
Robert Ferone
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI925778A0 publication Critical patent/FI925778A0/fi
Publication of FI925778A publication Critical patent/FI925778A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI925778A 1990-06-19 1992-12-18 Farmaceutiskt aktiva bensokinazolinfoereningar FI925778A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909013615A GB9013615D0 (en) 1990-06-19 1990-06-19 Pharmaceutical compounds
PCT/GB1991/000977 WO1991019700A1 (en) 1990-06-19 1991-06-18 Pharmaceutically active benzoquinazoline compounds

Publications (2)

Publication Number Publication Date
FI925778A0 true FI925778A0 (fi) 1992-12-18
FI925778A FI925778A (fi) 1992-12-18

Family

ID=10677828

Family Applications (1)

Application Number Title Priority Date Filing Date
FI925778A FI925778A (fi) 1990-06-19 1992-12-18 Farmaceutiskt aktiva bensokinazolinfoereningar

Country Status (26)

Country Link
US (4) US6090941A (fi)
EP (2) EP0535034B1 (fi)
JP (1) JP2966929B2 (fi)
KR (1) KR0183042B1 (fi)
CN (1) CN1049215C (fi)
AP (1) AP218A (fi)
AT (2) ATE222243T1 (fi)
AU (1) AU639815B2 (fi)
CA (1) CA2085589C (fi)
CS (1) CS186391A3 (fi)
DE (2) DE69133088T2 (fi)
DK (2) DK0535034T3 (fi)
ES (2) ES2178632T3 (fi)
FI (1) FI925778A (fi)
GB (1) GB9013615D0 (fi)
HU (2) HUT62273A (fi)
IE (1) IE912073A1 (fi)
IL (1) IL98542A (fi)
MC (1) MC2290A1 (fi)
MY (1) MY107001A (fi)
NO (1) NO924929D0 (fi)
NZ (1) NZ238582A (fi)
PL (1) PL169927B1 (fi)
PT (1) PT98021B (fi)
WO (1) WO1991019700A1 (fi)
ZA (1) ZA914676B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6762188B1 (en) 1990-06-19 2004-07-13 Smithkline Beecham Corporation Pharmaceutically active benzoquinazoline compounds
GB9013615D0 (en) 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
GB9223352D0 (en) * 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds
GB9226842D0 (en) * 1992-12-23 1993-02-17 Wellcome Found Pharmaceutical compounds
GB9408936D0 (en) * 1994-05-05 1994-06-22 Cancer Res Inst Anti-cancer compounds
AU3883600A (en) 1999-03-16 2000-10-04 Regents Of The University Of California, The Glycosylated polyamines
US6531454B1 (en) 1999-03-16 2003-03-11 The Regents Of The University Of California Glycosylated polyamines and methods of use therefor
PL360470A1 (en) * 2000-06-09 2004-09-06 Osi Pharmaceuticals, Inc. Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
KR20040041177A (ko) * 2001-09-26 2004-05-14 바이엘 파마슈티칼스 코포레이션 당뇨병 치료제로서의 1,6-나프티리딘 유도체
CN100434425C (zh) * 2005-03-09 2008-11-19 首都师范大学 4-喹唑啉酮衍生物及其在抗肿瘤药物中的应用
EP1754484A1 (en) * 2005-08-17 2007-02-21 Dan Stoicescu Condensed pyrimidine derivatives as inhibitors of foic acid-dependent enzymes
ATE432955T1 (de) 2005-12-05 2009-06-15 Nitto Denko Corp Polyglutamat-aminosäure-konjugate und verfahren
GB0525069D0 (en) * 2005-12-08 2006-01-18 Novartis Ag Organic compounds
EP2079739A2 (en) 2006-10-04 2009-07-22 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
EP1958632A1 (en) 2007-02-14 2008-08-20 Dan Stoicescu Use of condensed pyrimidine derivatives for the treatment of autoimmune and inflammatory diseases
ES2430380T3 (es) * 2007-05-09 2013-11-20 Nitto Denko Corporation Composiciones que incluyen un compuesto hidrófobo y un conjugado de poliaminoácido
CN101730549B (zh) * 2007-05-09 2015-12-09 日东电工株式会社 与铂类药物结合的聚合物
JP2010526917A (ja) * 2007-05-09 2010-08-05 日東電工株式会社 複数種の薬物を有するポリグルタミン酸塩複合体及びポリグルタミン酸塩−アミノ酸複合体
US8146622B2 (en) 2007-08-20 2012-04-03 Ford Global Technologies, Llc Switch and hose-valve connection arrangement for vehicle temporary mobility kit
US8517760B2 (en) 2007-08-20 2013-08-27 Ford Global Technologies, Llc Cord wrap and power plug receptacle arrangement for inflator
US8501242B2 (en) 2009-05-29 2013-08-06 University Of Florida Research Foundation Methods and compositions for treating neoplasia
CN101580501B (zh) * 2009-06-01 2011-03-09 南京卡文迪许生物工程技术有限公司 3-(取代二氢异吲哚酮-2-基)-2,6-哌啶二酮的合成方法及其中间体
WO2011078226A1 (ja) * 2009-12-22 2011-06-30 協和発酵キリン株式会社 三環系化合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UST862021I4 (en) * 1969-01-27 1969-05-27 Defensive publication
ZA72442B (en) * 1971-02-05 1972-10-25 Apaw Sa Automatic ice-cream machine
DE3069468D1 (en) * 1979-12-19 1984-11-22 Nat Res Dev Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents
US4814335A (en) * 1982-12-30 1989-03-21 Biomeasure, Incorporated Antiviral compounds
GB8513754D0 (en) * 1985-05-31 1985-07-03 Jones T R Anti-cancer quinazoline derivatives
US4603186A (en) 1985-10-21 1986-07-29 The Standard Oil Company Tetrapolymers containing indene
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
US4818819A (en) * 1986-10-20 1989-04-04 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
GB8707053D0 (en) * 1987-03-25 1987-04-29 Ici Plc Anti-tumour agents
US4857530A (en) * 1987-11-03 1989-08-15 Warner-Lambert Company Substituted quinazolinones as anticancer agents
US4902624A (en) * 1987-11-23 1990-02-20 Eastman Kodak Company Temperature cycling cuvette
GB8727737D0 (en) * 1987-11-26 1987-12-31 Ici Plc Antitumour agents
GB8829296D0 (en) * 1988-12-15 1989-01-25 Ici Plc Anti-tumour compounds
GB9013615D0 (en) * 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
US5405851A (en) * 1990-06-19 1995-04-11 Burroughs Wellcome Co. Pharmaceutical compounds

Also Published As

Publication number Publication date
EP0535034A1 (en) 1993-04-07
US5661155A (en) 1997-08-26
AU639815B2 (en) 1993-08-05
US5663337A (en) 1997-09-02
EP0535034B1 (en) 2002-08-14
IL98542A0 (en) 1992-07-15
ES2178632T3 (es) 2003-01-01
HUT62273A (en) 1993-04-28
CN1049215C (zh) 2000-02-09
HU211265A9 (en) 1995-11-28
NZ238582A (en) 1993-12-23
DK1199307T3 (da) 2004-06-14
DE69133088D1 (de) 2002-09-19
EP1199307B1 (en) 2004-02-25
CN1058208A (zh) 1992-01-29
ATE222243T1 (de) 2002-08-15
KR930701415A (ko) 1993-06-11
NO924929L (no) 1992-12-18
ZA914676B (en) 1993-02-24
HU9204011D0 (en) 1993-03-29
DK0535034T3 (da) 2002-12-09
FI925778A (fi) 1992-12-18
IL98542A (en) 1995-05-26
DE69133371D1 (de) 2004-04-01
AU8094391A (en) 1992-01-07
CA2085589A1 (en) 1991-12-20
DE69133088T2 (de) 2003-03-20
CA2085589C (en) 2001-12-18
AP218A (en) 1992-09-27
JP2966929B2 (ja) 1999-10-25
WO1991019700A1 (en) 1991-12-26
MC2290A1 (fr) 1993-07-14
EP1199307A1 (en) 2002-04-24
PL169927B1 (pl) 1996-09-30
IE912073A1 (en) 1992-01-01
MY107001A (en) 1995-08-30
DE69133371T2 (de) 2005-01-27
GB9013615D0 (en) 1990-08-08
PT98021A (pt) 1992-04-30
US6090941A (en) 2000-07-18
CS186391A3 (en) 1992-04-15
US6306865B1 (en) 2001-10-23
AP9100283A0 (en) 1991-07-31
ATE260262T1 (de) 2004-03-15
JPH05507704A (ja) 1993-11-04
ES2211851T3 (es) 2004-07-16
PT98021B (pt) 1998-11-30
KR0183042B1 (ko) 1999-05-01
NO924929D0 (no) 1992-12-18

Similar Documents

Publication Publication Date Title
FI934914A (fi) Farmaceutiska formuleringar
FI925778A0 (fi) Farmaceutiskt aktiva bensokinazolinfoereningar
DK0515312T3 (da) Farmaceutisk præparat
DK481989A (da) Farmaceutiske formuleringer
FI921060A (fi) Farmaceutiska aerosolformuleringar
FI922958A (fi) Farmaceutisk sammansaettning
FI922252A (fi) Farmaceutisk sammansaettning
KR970006279A (ko) 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물
MX9102473A (es) Agentes farmaceuticos.
NO305786B1 (no) Medikamentpakke
FI923581A (fi) Farmaceutisk kombinationsformation
FI930882A0 (fi) Farmaceutiska foereningar
NO923859D0 (no) Medikament
FI931251A0 (fi) Farmaceutiska foereningar
FI933808A0 (fi) Insekticidiskt aktiva peptider
DK0511991T3 (da) Farmaceutisk formulering
DK137591D0 (da) Fast farmaceutisk praeparat
DE69130099D1 (de) Antineoplastischer wirkstoff
KR920007598U (ko) 의약용 캅셀
KR920010907U (ko) 약제 살포기
DK204190D0 (da) Farmaceutisk praeparat
DK207590D0 (da) Farmaceutisk praeparat
NO920564D0 (no) Farmasoeytiske adenosinholdige preparater
ITMI910596A1 (it) Gliceroderivati farmacologicamente attivi
IT8922215A0 (it) Formulazioni farmaceutiche.

Legal Events

Date Code Title Description
FD Application lapsed